Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2025)
Cellebrite DI's Cash & Current Investments history spans 6 years, with the latest figure at $285.5 million for Q4 2025.
- Quarterly Cash & Current Investments fell 17.34% to $285.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $285.5 million through Dec 2025, down 17.34% year-over-year, with the annual reading at $285.5 million for FY2025, 17.34% down from the prior year.
- Cash & Current Investments came in at $285.5 million for Q4 2025, up from $281.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $345.4 million in Q4 2024 to a low of $90.5 million in Q1 2025.
- The 5-year median for Cash & Current Investments is $139.4 million (2021), against an average of $162.5 million.
- Year-over-year, Cash & Current Investments crashed 33.25% in 2022 and then soared 106.35% in 2025.
- Cellebrite DI's Cash & Current Investments stood at $133.8 million in 2021, then dropped by 1.16% to $132.3 million in 2022, then soared by 72.51% to $228.2 million in 2023, then soared by 51.35% to $345.4 million in 2024, then decreased by 17.34% to $285.5 million in 2025.
- Per Business Quant, the three most recent readings for CLBT's Cash & Current Investments are $285.5 million (Q4 2025), $281.4 million (Q3 2025), and $179.2 million (Q2 2025).